Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
47
ZBH Quote, Financials, Valuation and Earnings
Last price:
$94.26
Seasonality move
:
7.29%
Day range:
$93.23 - $94.76
52-week range:
$85.33 - $114.44
Dividend yield:
1.02%
P/E ratio:
23.33x
P/S ratio:
2.34x
P/B ratio:
1.46x
Volume:
2.3M
Avg. volume:
2.3M
1-year change:
-13.63%
Market cap:
$18.7B
Revenue:
$7.7B
EPS (TTM):
$4.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$2.1B | $1.92 | 9.94% | 100.21% | $102.92 |
|
EW
Edwards Lifesciences Corp.
|
$1.6B | $0.68 | 11.11% | -5.53% | $95.41 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.6B | $2.12 | 12.86% | 18.99% | $596.36 |
|
NTRB
Nutriband, Inc.
|
$765K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
RMD
ResMed, Inc.
|
$1.4B | $2.77 | 8.96% | 15.63% | $293.47 |
|
SYK
Stryker Corp.
|
$6.3B | $3.06 | 10.61% | 210.56% | $429.31 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$94.28 | $102.92 | $18.7B | 23.33x | $0.24 | 1.02% | 2.34x |
|
EW
Edwards Lifesciences Corp.
|
$86.19 | $95.41 | $50B | 36.69x | $0.00 | 0% | 8.61x |
|
ISRG
Intuitive Surgical, Inc.
|
$575.34 | $596.36 | $204B | 76.15x | $0.00 | 0% | 21.76x |
|
NTRB
Nutriband, Inc.
|
$4.82 | $15.00 | $57.9M | -- | $0.00 | 0% | 20.81x |
|
RMD
ResMed, Inc.
|
$256.55 | $293.47 | $37.4B | 26.26x | $0.60 | 0.88% | 7.18x |
|
SYK
Stryker Corp.
|
$364.02 | $429.31 | $139.2B | 47.80x | $0.84 | 0.92% | 5.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
38.87% | -0.489 | 41.53% | 1.20x |
|
EW
Edwards Lifesciences Corp.
|
6.42% | -0.140 | 1.55% | 2.86x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.065 | -- | 3.42x |
|
NTRB
Nutriband, Inc.
|
3.08% | 2.796 | 0.31% | 4.55x |
|
RMD
ResMed, Inc.
|
12.15% | 0.692 | 2.12% | 1.89x |
|
SYK
Stryker Corp.
|
44.02% | 0.583 | 12.35% | 0.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ZBH
Zimmer Biomet Holdings, Inc.
|
$1.3B | $330.7M | 4.11% | 6.45% | 16.52% | $267.7M |
|
EW
Edwards Lifesciences Corp.
|
$1.2B | $433.1M | 12.34% | 13.19% | 27.89% | $516.2M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
|
NTRB
Nutriband, Inc.
|
$156.9K | -$2M | -114.42% | -117.44% | -321.8% | -$1.3M |
|
RMD
ResMed, Inc.
|
$808.9M | $462.3M | 22.25% | 25.6% | 34.62% | $411.5M |
|
SYK
Stryker Corp.
|
$3.7B | $1.4B | 7.89% | 14.06% | 22.52% | $1.4B |
Zimmer Biomet Holdings, Inc. vs. Competitors
-
Which has Higher Returns ZBH or EW?
Edwards Lifesciences Corp. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 18.82%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B EWEdwards Lifesciences Corp.78.29% $0.50 $10.9B -
What do Analysts Say About ZBH or EW?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.92, signalling upside risk potential of 9.16%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $95.41 which suggests that it could grow by 10.49%. Given that Edwards Lifesciences Corp. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Edwards Lifesciences Corp. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 17 1 EWEdwards Lifesciences Corp.15 14 0 -
Is ZBH or EW More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.615, which suggesting that the stock is 38.541% less volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.229%.
-
Which is a Better Dividend Stock ZBH or EW?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or EW?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are larger than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than Edwards Lifesciences Corp.'s net income of $292.3M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.33x while Edwards Lifesciences Corp.'s PE ratio is 36.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 8.61x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.33x $2B $231.2M EWEdwards Lifesciences Corp.8.61x 36.69x $1.6B $292.3M
-
Which has Higher Returns ZBH or ISRG?
Intuitive Surgical, Inc. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 28.31%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About ZBH or ISRG?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.92, signalling upside risk potential of 9.16%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $596.36 which suggests that it could grow by 3.65%. Given that Zimmer Biomet Holdings, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe Zimmer Biomet Holdings, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 17 1 ISRGIntuitive Surgical, Inc.15 10 1 -
Is ZBH or ISRG More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.615, which suggesting that the stock is 38.541% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock ZBH or ISRG?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or ISRG?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.33x while Intuitive Surgical, Inc.'s PE ratio is 76.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 21.76x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.33x $2B $231.2M ISRGIntuitive Surgical, Inc.21.76x 76.15x $2.5B $709.2M
-
Which has Higher Returns ZBH or NTRB?
Nutriband, Inc. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of -321.33%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Nutriband, Inc.'s return on equity of -117.44%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B NTRBNutriband, Inc.25.21% -$2.12 $8.8M -
What do Analysts Say About ZBH or NTRB?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.92, signalling upside risk potential of 9.16%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 211.2%. Given that Nutriband, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Nutriband, Inc. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 17 1 NTRBNutriband, Inc.1 0 0 -
Is ZBH or NTRB More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.615, which suggesting that the stock is 38.541% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock ZBH or NTRB?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend. Zimmer Biomet Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or NTRB?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are larger than Nutriband, Inc. quarterly revenues of $622.5K. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is higher than Nutriband, Inc.'s net income of -$2M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.33x while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 20.81x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.33x $2B $231.2M NTRBNutriband, Inc.20.81x -- $622.5K -$2M
-
Which has Higher Returns ZBH or RMD?
ResMed, Inc. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 26.1%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat ResMed, Inc.'s return on equity of 25.6%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B RMDResMed, Inc.60.56% $2.37 $7B -
What do Analysts Say About ZBH or RMD?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.92, signalling upside risk potential of 9.16%. On the other hand ResMed, Inc. has an analysts' consensus of $293.47 which suggests that it could grow by 14.39%. Given that ResMed, Inc. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe ResMed, Inc. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 17 1 RMDResMed, Inc.9 6 1 -
Is ZBH or RMD More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.615, which suggesting that the stock is 38.541% less volatile than S&P 500. In comparison ResMed, Inc. has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.363%.
-
Which is a Better Dividend Stock ZBH or RMD?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. ResMed, Inc. offers a yield of 0.88% to investors and pays a quarterly dividend of $0.60 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. ResMed, Inc. pays out 22.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or RMD?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are larger than ResMed, Inc. quarterly revenues of $1.3B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than ResMed, Inc.'s net income of $348.5M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.33x while ResMed, Inc.'s PE ratio is 26.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 7.18x for ResMed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.33x $2B $231.2M RMDResMed, Inc.7.18x 26.26x $1.3B $348.5M
-
Which has Higher Returns ZBH or SYK?
Stryker Corp. has a net margin of 11.55% compared to Zimmer Biomet Holdings, Inc.'s net margin of 14.18%. Zimmer Biomet Holdings, Inc.'s return on equity of 6.45% beat Stryker Corp.'s return on equity of 14.06%.
Company Gross Margin Earnings Per Share Invested Capital ZBHZimmer Biomet Holdings, Inc.62.7% $1.16 $20.9B SYKStryker Corp.61.86% $2.22 $38.9B -
What do Analysts Say About ZBH or SYK?
Zimmer Biomet Holdings, Inc. has a consensus price target of $102.92, signalling upside risk potential of 9.16%. On the other hand Stryker Corp. has an analysts' consensus of $429.31 which suggests that it could grow by 17.94%. Given that Stryker Corp. has higher upside potential than Zimmer Biomet Holdings, Inc., analysts believe Stryker Corp. is more attractive than Zimmer Biomet Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ZBHZimmer Biomet Holdings, Inc.5 17 1 SYKStryker Corp.13 9 0 -
Is ZBH or SYK More Risky?
Zimmer Biomet Holdings, Inc. has a beta of 0.615, which suggesting that the stock is 38.541% less volatile than S&P 500. In comparison Stryker Corp. has a beta of 0.890, suggesting its less volatile than the S&P 500 by 11.047%.
-
Which is a Better Dividend Stock ZBH or SYK?
Zimmer Biomet Holdings, Inc. has a quarterly dividend of $0.24 per share corresponding to a yield of 1.02%. Stryker Corp. offers a yield of 0.92% to investors and pays a quarterly dividend of $0.84 per share. Zimmer Biomet Holdings, Inc. pays 21.66% of its earnings as a dividend. Stryker Corp. pays out 41.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ZBH or SYK?
Zimmer Biomet Holdings, Inc. quarterly revenues are $2B, which are smaller than Stryker Corp. quarterly revenues of $6.1B. Zimmer Biomet Holdings, Inc.'s net income of $231.2M is lower than Stryker Corp.'s net income of $859M. Notably, Zimmer Biomet Holdings, Inc.'s price-to-earnings ratio is 23.33x while Stryker Corp.'s PE ratio is 47.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Zimmer Biomet Holdings, Inc. is 2.34x versus 5.77x for Stryker Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ZBHZimmer Biomet Holdings, Inc.2.34x 23.33x $2B $231.2M SYKStryker Corp.5.77x 47.80x $6.1B $859M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
